Summary
-
1.
A model is presented that predicts the double log relationship between the agonist concentration ratio \t-1 against antagonist concentration for the case of two receptor subtypes mediating the same qualitative effect of an agonist and interacting with both agonist and antagonist. The relationship is a nonlinear function which is approximated for small and high antagonist concentrations by two lines of slope 1.0 united by an inflection. The function depends on the concentration of the antagonist, on the two equilibrium dissociation constants K BQ and K BR for the corresponding complexes of agonist-receptor-subtype and on the fractional stimuli σQ = 1 − σR generated by the agonist via the receptor-subtypes Q and R.
-
2.
To test the model, the antagonism of the effects of 4 agonists was investigated with 9 antagonist concentrations in a single guinea-pig trachea. Optically pure (+)-bupranolol was used as an antagonist selective for \gb-adrenoceptor subtypes. (+)-Bupranolol blocked the relaxant effects of (\+-)-salbutamol, (\t-)-adrenaline and (\t-)-isoprenaline to the same extent whereas the effects of (\t-)-noradrenaline were blocked less effectively.
Experimental points of the double-log plots were well approximated by the non-linear functions based upon the two-receptor model. 77% of the relaxant effects of (−)-noradrenaline (σQ = 0.77) appear to be mediated through a low-affinity (K BQ=45 nmol/l) β-adrenoceptor subtype; 23% (σQ = 0.23) through a high-affinity (K BR=3.1 nmol/l) β-adrenoceptor subtype for (+)-bupranolol. (−)-Adrenaline, (−)-isoprenaline and (±)-salbutamol caused most of their effects (93%, 92% and 99%, respectively) through the high-affinity R-subtype.
-
3.
In contrast to (+)-bupranolol, the antagonism of the relaxant effects of agonists by (\t-)-bupranolol were nearly independent of the agonist used. K B-values between 0.2 and 0.4 nmol/l were estimated for the (\t-)-bupranolol-\gb-adrenoceptor complex of the trachea. The enantiomeric affinity ratio (i.e. K BQ(+)-bupranolol/K B(\t-)-bupranolol) was 102 for \gb-adrenoceptors (Q-subtype) activated predominantly by (\t-)-noradrenaline. The enantiomeric affinity ratio was 14 for \gb-adrenoceptors (R-subtype) activated mostly by (\t-)-adrenaline, (\t-)-isoprenaline and (\+-)-salbutamol.
-
4.
In guinea-pig right atria, the blocking potencies of both (\t-)-bupranolol and (+)-bupranolol were nearly independent of the used agonist. The enantiomeric affinity ratio of bupranolol was 89 for sinoatrial \gb-adrenoceptors. The agreement of this ratio with that for Q-receptors of tracheae suggests that most sinoatrial \gb-adrenoceptors resemble the tracheal Q-receptors.
-
5.
Tissue selectivities (i.e. tracheal/sinoatrial affinity ratios) were agonist-dependent. Against (\t-)-noradrenaline the ratio was less than 2 for both (+)-bupranolol and (\t-)-bupranolol. Against (\t-)-adrenaline, (\t-)-isoprenaline and (\+-)-salbutamol the ratio was 26 for (+)-bupranolol and 4 for (\t-)-bupranolol.
Similar content being viewed by others
References
Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58
Blinks JR (1965) Convenient appraratus for recording contractions of isolated muscle. J Appl Physiol 20:755–757
Bryan LJ, O'Donnell SR (1980) Affinities of catecholamines for extraneuronal uptake in smooth muscle cells in tracheal muscle of guinea pig. Naunyn-Schmiedeberg's Arch Pharmacol 311:139–146
Chahl LA, O'Donnell SR (1967) The interaction of cocaine and propranolol with catecholamine on guinea-pig trachea. Eur J Pharmacol 2:77–82
Dixon WJ, Brown MB (eds) (1979) Biocmedical computer programs, P series. University of California Press, Berkeley Los Angeles London
Engel G, Hoyer D, Berthold R, Wagner H (1981) (±)-[125Iodo]-cyanpindolol, a new ligand for β-adrenoceptors: identification and quantitation of subclasses of β-adrenoceptors in guinea pig. Naunyn-Schmiedeberg's Arch Pharmacol 317:277–285
Foster RW (1967) The potentiation of the responses to noradrenaline and isoprenaline of guinea-pig isolated tracheal chain preparation by desipramine, cocaine, phentolamine, phenoxybenzamine, guanethidine, metanephrine and cooling. Br J Pharmacol 31:466–482
Foster RW (1969) An uptake of radioactivity from (±)-3H-isoprenaline and its inhibition by drugs which potentiate the responses to (−)-isoprenaline in the guinea-pig isolated trachea. Br J Pharmacol 35:418–427
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines. Springer, Berlin Heidelberg New York, pp 283–335
Furchgott RF (1976) Postsynaptic adrenergic receptor mechanisms in vascular smooth muscle. In: Bevan JA (ed) Vascular neuroeffector mechanisms, 2nd Int Symp Odense. Karger, Basel, pp 131–142
Furchgott RF (1978) Pharmacological characterization of receptors: its relation to radioligand-binding studies. Fed Proc 37, No 2:115–120
Kaumann AJ (1978) On spare β-adrenoceptors for inotropic effects of catecholamines in kitten ventricle. Naunyn-Schmiedeberg's Arch Pharmacol 305:97–102
Kaumann AJ, Lemoine H (1978) Vergleich der Affinitäten von Bupranolol und seinen Metaboliten mit denen anderer β-Rezeptor-Hemmer. In: Rahn KH, Schrey A (eds) Betablocker. Urban & Schwarzenberg, München Wien Baltimore, pp 4–8
Kaumann AJ, Blinks JR (1980) Stimulant and depressant effects of β-adrenoceptor blocking agents on isolated heart muscle: A positive inotropic effect not mediated through adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 311:205–218
Kaumann AJ, Marano M (1982) On equilibrium constants for complexes of drug-receptor subtypes. Selective and non-selective interactions of partial agonists with two plausible β-adrenoceptor subtypes mediating positive chronotropic effects of (−)-isoprenaline in kitten atria. Naunyn-Schmiedeberg's Arch Pharmacol 318:192–201
Kaumann AJ, Birbaumer L, Wittmann R (1978) Heart β-adrenoceptors. In: O'Malley BW, Birnbaumer L (eds) Hormone receptors, vol 3. Academic Press, New York, pp 133–177
Kaumann AJ, McInerny TK, Gilmour DP, Blinks JR (1980) Comparative assessment of β-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: Similarity of inotropic and chronotropic blocking potencies against isoproterenol. Naunyn-Schmiedeberg's Arch Pharmacol 311:219–236
Kaumann AJ, Morris TH, Bojar H (1983) Heart β-receptors: on the functional role of heterogeneous binding sites. J Receptor Res (in press)
Kenakin TP (1982) The Schild regression in the process of receptor classification. Can J Physiol Pharmacol 60:249–265
Lemoine H, Kaumann AJ (1980) Agonist-dependent enantiomeric affinity ratios of bupranolol (BU) as a tool for the differentiation of heart- and tracheal β-adrenoceptors using 99.99% optically pure (+)-bupranolol. Naunyn-Schmiedeberg's Arch Pharmacol 311:R60
Lemoine H, Kaumann AJ (1982) A novel analysis of concentration-dependence of partial agonism. Ring-demethylation of bupranolol results in a high affinity partial agonist (K 105) for myocardial and tracheal β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 320:130–144
Marano M, Kaumann AJ (1976) On the statistics of drug-receptor constants for partial agonists. J Pharmacol Exp Ther 198:518–525
Minneman KP, Hegstrand LR, Molinoff PB (1979) The pharmacological specificity of β1- and β2-adrenergic receptors in rat heart and lung in vitro. Mol Pharmacol 16:21–33
O'Donnell SR, Wanstall JC (1979) The importance of choice of agonist in studies designed to predict β2:β1 adrenoceptor selectivity of antagonists from pA2 values on guinea-pig trachea and atria. Naunyn-Schmiedeberg's Arch Pharmacol 308:183–190
Patil PN, Miller DD, Trendelenburg U (1975) Molecular geometry and adrenergic drug activity. Pharmacol Rev 26:323–392
Rugg EL, Barnett DB, Nahorski SR (1978) Coexistence of β1- and β2-adrenoreceptors in mammalian lung. Evidence from direct binding studies. Mol Pharmacol 14:996–1005
Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol 11:379–393
Trendelenburg U (1968) The effect of cocaine on the pacemaker of isolated guinea-pig atria. J Pharmacol Exp Ther 161:222–231
Wächter W, Münch U, Lemoine H, Kaumann AJ (1980) Evidence that (+)-bupranolol interacts directly with myocardial β-adrenoceptors: Control of optical purity with differential thermal analysis. Naunyn-Schmiedeberg's Arch Pharmacol 313:1–8
Walter M, Lemoine H, Kaumann AJ (1982) Dissociation between stimulation and blockade (DSB) with optical isomers of pindolol on trachea and heart. The role of β-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 321:R21
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lemoine, H., Kaumann, A.J. A model for the interaction of competitive antagonists with two receptor-subtypes characterized by a schild-plot with apparent slope unity. Naunyn-Schmiedeberg's Arch. Pharmacol. 322, 111–120 (1983). https://doi.org/10.1007/BF00512383
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00512383